Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1903 2
2002 8
2003 12
2004 10
2005 8
2006 7
2007 8
2008 16
2009 16
2010 18
2011 18
2012 11
2013 18
2014 11
2015 21
2016 16
2017 16
2018 24
2019 18
2020 25
2021 32
2022 28
2023 31
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

329 results

Results by year

Filters applied: . Clear all
Page 1
Improved survival with ipilimumab in patients with metastatic melanoma.
Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbé C, Peschel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A, Urba WJ. Hodi FS, et al. Among authors: clark ji. N Engl J Med. 2010 Aug 19;363(8):711-23. doi: 10.1056/NEJMoa1003466. Epub 2010 Jun 5. N Engl J Med. 2010. PMID: 20525992 Free PMC article. Clinical Trial.
Pharmacological Imperialism.
Currow DC Senior Associate Editor, Clark J. Currow DC Senior Associate Editor, et al. Among authors: clark j. J Palliat Med. 2023 Feb;26(2):158-159. doi: 10.1089/jpm.2022.0573. J Palliat Med. 2023. PMID: 36724313 No abstract available.
Real-time dynamic single-molecule protein sequencing on an integrated semiconductor device.
Reed BD, Meyer MJ, Abramzon V, Ad O, Ad O, Adcock P, Ahmad FR, Alppay G, Ball JA, Beach J, Belhachemi D, Bellofiore A, Bellos M, Beltrán JF, Betts A, Bhuiya MW, Blacklock K, Boer R, Boisvert D, Brault ND, Buxbaum A, Caprio S, Choi C, Christian TD, Clancy R, Clark J, Connolly T, Croce KF, Cullen R, Davey M, Davidson J, Elshenawy MM, Ferrigno M, Frier D, Gudipati S, Hamill S, He Z, Hosali S, Huang H, Huang L, Kabiri A, Kriger G, Lathrop B, Li A, Lim P, Liu S, Luo F, Lv C, Ma X, McCormack E, Millham M, Nani R, Pandey M, Parillo J, Patel G, Pike DH, Preston K, Pichard-Kostuch A, Rearick K, Rearick T, Ribezzi-Crivellari M, Schmid G, Schultz J, Shi X, Singh B, Srivastava N, Stewman SF, Thurston TR, Thurston TR, Trioli P, Tullman J, Wang X, Wang YC, Webster EAG, Zhang Z, Zuniga J, Patel SS, Griffiths AD, van Oijen AM, McKenna M, Dyer MD, Rothberg JM. Reed BD, et al. Among authors: clark j. Science. 2022 Oct 14;378(6616):186-192. doi: 10.1126/science.abo7651. Epub 2022 Oct 13. Science. 2022. PMID: 36227977
EDITORIAL COMMENT.
Clark JY. Clark JY. Urology. 2022 Aug;166:256. doi: 10.1016/j.urology.2022.03.044. Urology. 2022. PMID: 35908840 No abstract available.
EDITORIAL COMMENT.
Clark JY. Clark JY. Urology. 2022 Jun;164:271-272. doi: 10.1016/j.urology.2021.11.049. Urology. 2022. PMID: 35710174 No abstract available.
EDITORIAL COMMENT.
Alzubaidi AN, Clark JY. Alzubaidi AN, et al. Among authors: clark jy. Urology. 2023 Oct;180:261. doi: 10.1016/j.urology.2023.06.033. Epub 2023 Aug 23. Urology. 2023. PMID: 37620208 No abstract available.
EDITORIAL COMMENT.
Feiertag JH, Clark JY. Feiertag JH, et al. Among authors: clark jy. Urology. 2023 Dec;182:236-237. doi: 10.1016/j.urology.2023.07.040. Epub 2023 Oct 26. Urology. 2023. PMID: 37891029 No abstract available.
Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial.
Ryan CW, Tangen CM, Heath EI, Stein MN, Meng MV, Alva AS, Pal SK, Puzanov I, Clark JI, Choueiri TK, Agarwal N, Uzzo RG, Haas NB, Synold TW, Plets M, Vaishampayan UN, Shuch BM, Thompson IM Jr, Lara PN Jr. Ryan CW, et al. Among authors: clark ji. Lancet. 2023 Sep 23;402(10407):1043-1051. doi: 10.1016/S0140-6736(23)00913-3. Epub 2023 Jul 28. Lancet. 2023. PMID: 37524096 Clinical Trial.
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells.
Hendel A, Bak RO, Clark JT, Kennedy AB, Ryan DE, Roy S, Steinfeld I, Lunstad BD, Kaiser RJ, Wilkens AB, Bacchetta R, Tsalenko A, Dellinger D, Bruhn L, Porteus MH. Hendel A, et al. Among authors: clark jt. Nat Biotechnol. 2015 Sep;33(9):985-989. doi: 10.1038/nbt.3290. Epub 2015 Jun 29. Nat Biotechnol. 2015. PMID: 26121415 Free PMC article.
EDITORIAL COMMENT.
Clark JY. Clark JY. Urology. 2022 Feb;160:33. doi: 10.1016/j.urology.2021.09.042. Urology. 2022. PMID: 35216703 No abstract available.
329 results